Stockscreener 앱 받기
0.1028
7.64%
0.0073
전일 마감가:
$0.0955
열려 있는:
$0.0946
하루 거래량:
4.22M
Relative Volume:
0.29
시가총액:
$14.83M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.0761
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
-2.00%
1개월 성능:
+5.87%
6개월 성능:
-76.11%
1년 성능:
-82.67%
1일 변동 폭
$0.093
$0.105
1주일 범위
$0.0902
$0.1067
52주 변동 폭
$0.09
$1.50
Applied Therapeutics Inc Stock (APLT) Company Profile
명칭
Applied Therapeutics Inc
전화
212-220-9226
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.1028 | 13.78M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.90 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.45 | 78.77B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
840.50 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
338.06 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.38 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-12-03 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-12-23 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 개시 | William Blair | Outperform |
| 2024-03-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-22 | 개시 | Leerink Partners | Outperform |
| 2022-01-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-08-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-04-22 | 개시 | Goldman | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-06-10 | 개시 | Citigroup | Buy |
| 2019-06-10 | 개시 | Cowen | Outperform |
| 2019-06-10 | 개시 | Robert W. Baird | Outperform |
모두보기
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
Published on: 2026-02-01 03:43:48 - baoquankhu1.vn
Cycle Pharmaceuticals Announces Further Extension of Applied Therapeutics Tender Offer - marketscreener.com
Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer - Business Wire
Cycle extends tender offer deadline for Applied Therapeutics acquisition By Investing.com - Investing.com Nigeria
What chart patterns are forming on Applied Therapeutics Inc.Layoff News & Detailed Earnings Play Alerts - mfd.ru
Applied Therapeutics (APLT) Updates on Cycle Group's Acquisition Offer - GuruFocus
Cycle extends tender offer deadline for Applied Therapeutics acquisition - Investing.com
Applied Therapeutics (NASDAQ: APLT) extends tender offer, 44% of shares tendered - Stock Titan
Applied Therapeutics Shares Letter to Stockholders - GlobeNewswire
Applied Therapeutics warns: tender now or risk getting nothing - Stock Titan
Acquisition of Applied Therapeutics Nears Finalization - AD HOC NEWS
APLT Stock Price, Forecast & Analysis | APPLIED THERAPEUTICS INC (NASDAQ:APLT) - Chartmill
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) - GuruFocus
Applied Therapeutics chief medical officer sells $52,507 in stock - MSN
Will Applied Therapeutics Inc. stock see insider buyingSector Performance Drivers & Free Take Advantage Of Momentum - Bollywood Helpline
Insider Trends: What are Applied Therapeutics Incs recent SEC filings showingWeekly Stock Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Why RF Industries Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Trend Review: Why Applied Therapeutics Inc stock is rated strong buy2025 Investor Takeaways & Accurate Trade Setup Notifications - Bộ Nội Vụ
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - MSN
Why Applied Therapeutics Inc. stock attracts global investorsWeekly Loss Report & AI Forecast Swing Trade Picks - Улправда
Support Test: Why Applied Therapeutics Inc. stock attracts global investorsTrend Reversal & Low Drawdown Momentum Ideas - Улправда
Leerink Partners downgrades Applied Therapeutics (APLT) - MSN
Bond Watch: Will Applied Therapeutics Inc. stock continue dividend increasesDip Buying & Daily Technical Forecast Reports - Улправда
Can Applied Therapeutics Inc. stock beat analyst upgradesJuly 2025 Selloffs & AI Enhanced Trading Signals - Улправда
Will Applied Therapeutics Inc. stock continue dividend increasesWeekly Market Report & Free Technical Pattern Based Buy Signals - Улправда
Aug Analyst Calls: Will Applied Therapeutics Inc. stock see insider buyingJuly 2025 Fed Impact & Low Risk Entry Point Guides - Улправда
Why Applied Therapeutics Inc. (2UV) stock is upgraded to buyTrade Analysis Report & Weekly Watchlist of Top Performers - Улправда
Published on: 2026-01-07 21:50:31 - ulpravda.ru
RSI Check: Why Applied Therapeutics Inc stock attracts global investorsJuly 2025 Technicals & Growth-Oriented Investment Plans - Bộ Nội Vụ
Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options - MSN
EBITDA per share of Applied Therapeutics, Inc. – FWB:2UV - TradingView — Track All Markets
Applied Therapeutics $15M Securities Class Action Settlement - Claim Depot
Applied Therapeutics (NASDAQ: APLT) tender offer extended to February 2, 2026 - Stock Titan
APLT DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class ActionAPLT - Macau Business
Applied Therapeutics (APLT) price target decreased by 85.00% to 0.26 - MSN
Why Applied Therapeutics Inc. stock remains a top recommendationMarket Sentiment Summary & Fast Moving Trade Plans - bolumsonucanavari.com
What analyst consensus says on Applied Therapeutics Inc. stockStop Loss & Risk Managed Investment Strategies - Улправда
Is Applied Therapeutics Inc. (2UV) stock cheap vs fundamentalsWeekly Stock Summary & Real-Time Market Sentiment Reports - Улправда
Will Applied Therapeutics Inc. stock maintain momentum in 2025 - Bölüm Sonu Canavarı
Is Applied Therapeutics Inc. stock a safe buy before earningsQuarterly Market Review & Fast Gaining Stock Strategy Reports - Улправда
How Applied Therapeutics Inc. (2UV) stock stacks up against competitorsMarket Performance Report & Safe Swing Trade Setup Alerts - DonanımHaber
Why Applied Therapeutics Inc. stock is recommended by analysts2025 Fundamental Recap & Long-Term Investment Growth Plans - Улправда
Applied Therapeutics, Inc.(NasdaqCM: APLT) dropped from NASDAQ Biotechnology Index - marketscreener.com
Published on: 2025-12-19 02:08:41 - Улправда
Dir Kanter Sells 43,000 ($4.8K) Of Applied Therapeutics Inc [APLT] - TradingView — Track All Markets
Applied Therapeutics (APLT) director reports sale of 43,000 shares on Form 4 - Stock Titan
Published on: 2025-12-18 17:03:31 - Улправда
Applied Therapeutics Earnings Notes - Trefis
United StatesGoodwin Represents Cycle Pharmaceuticals In Acquisition Of Applied Therapeutics - Mondaq
Here's Why Applied Therapeutics (APLT) Is a Great 'Buy the Bottom' Stock Now - Finviz
Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights - Sahm
Applied Therapeutics Inc (APLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.27%
자본화:
|
볼륨(24시간):